CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 1 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,206,106 | +545.0% | 206,525 | +365.6% | 0.06% | +463.6% |
Q2 2022 | $187,000 | -95.0% | 44,357 | -84.9% | 0.01% | -91.9% |
Q4 2020 | $3,709,000 | +37.4% | 293,443 | +30.5% | 0.14% | -67.1% |
Q2 2019 | $2,699,000 | -0.6% | 224,900 | 0.0% | 0.41% | +6.2% |
Q1 2019 | $2,715,000 | – | 224,900 | – | 0.39% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 2,200,000 | $37,532,000 | 7.45% |
BVF INC/IL | 2,336,609 | $39,863,000 | 6.78% |
ISZO CAPITAL MANAGEMENT LP | 152,988 | $2,610,000 | 4.54% |
SENZAR ASSET MANAGEMENT, LLC | 416,845 | $7,111,000 | 1.80% |
INGALLS & SNYDER LLC | 1,056,000 | $18,015,000 | 0.96% |
Lyon Street Capital, LLC | 86,011 | $1,467,000 | 0.59% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 430,982 | $7,353,000 | 0.25% |
AWM Investment Company, Inc. | 137,212 | $2,340,000 | 0.22% |
ACUTA CAPITAL PARTNERS, LLC | 49,051 | $837,000 | 0.20% |
Schonfeld Strategic Advisors LLC | 61,831 | $1,055,000 | 0.11% |